Lumida
/LBRX
⌘K
LBRX

LBRX

LBRX
$44.63USD↓-3.50%-1.62 today

MARKET CAP

1.4B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$44 – $48

52W RANGE

$13
$50

AI Summary

Stalk
Buy NowHigh

The stock is in a strong multi-month uptrend, coiling in an ascending-triangle consolidation at its 52-week high. Price is supported by all rising EMAs and the 200-day SMA, while momentum indicators (RSI and Options Score) suggest further upside is likely. Medium-term bias remains bullish, and short-term conditions are favorable for immediate participation either on minor pullbacks into the 20-day EMA or a breakout above the $49.50 resistance on rising volume.

  • ↑LB-102 showed statistically significant Phase 2 NOVA-1 trial efficacy for acute schizophrenia.
  • ↑H.C. Wainwright raised its price target to $60, implying ~43% upside.
  • ↓Earnings yield at –1.49 and profitability score –0.67 expose weak fundamentals.
Full analysis →

Buying

5

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY2.73 M88.74 M+263.46 K+45.6%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.50 M48.87 M+69.72 K+47.2%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL921.47 K29.91 M+-2.22 K+31.3%0.04%
MM

Millennium Management LLC

Q2 2026

BUY259.22 K8.41 M+122.25 K+149.1%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL215.97 K7.01 M+-200.94 K-31.8%0.00%
EP

Eversept Partners, LP

Q2 2026

BUY183.66 K5.96 M+83.47 K+141.2%0.31%
JH

Janus Henderson Group Plc

Q1 2026

BUYNEW130.86 K3.23 M+130.86 K+0.0%0.00%